|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 195.50 USD | +2.25% |
|
+5.47% | +11.09% |
| 02-12 | Analyst recommendations: Pfizer, Applovin, Biogen, Hilton, Snap… |  |
| 02-12 | Biogen Inc. Announces Board Changes | CI |
| Capitalization | 28.69B 24.18B 22.07B 21.06B 39.11B 2,599B 40.45B 256B 102B 1,252B 108B 105B 4,374B | P/E ratio 2026 * |
16.5x | P/E ratio 2027 * | 15.7x |
|---|---|---|---|---|---|
| Enterprise value | 28.64B 24.14B 22.03B 21.03B 39.05B 2,595B 40.38B 256B 102B 1,250B 107B 105B 4,366B | EV / Sales 2026 * |
3.04x | EV / Sales 2027 * | 2.72x |
| Free-Float |
85.5% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Biogen Inc.
| 1 day | +2.25% | ||
| 1 week | +5.47% | ||
| Current month | +8.68% | ||
| 1 month | +5.32% | ||
| 3 months | +21.07% | ||
| 6 months | +51.63% | ||
| Current year | +11.09% |
| 1 week | 187.2 |  | 201 |
| 1 month | 160.36 | | 202.41 |
| Current year | 160.36 | | 202.41 |
| 1 year | 110.04 | | 202.41 |
| 3 years | 110.04 | | 319.76 |
| 5 years | 110.04 | | 468.55 |
| 10 years | 110.04 | | 468.55 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 65 | 14/11/2022 | |
Robin Kramer
DFI | Director of Finance/CFO | 60 | 01/03/2025 |
Jane Grogan
CTO | Chief Tech/Sci/R&D Officer | 59 | 02/10/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Caroline Dorsa
CHM | Chairman | 66 | 26/06/2023 |
Eric Rowinsky
BRD | Director/Board Member | 69 | 23/03/2010 |
Stephen Sherwin
BRD | Director/Board Member | 77 | 01/01/2010 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | 0.00% | 4.3% | 1 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.25% | +5.47% | +46.52% | -31.71% | 28.69B | |
| +0.60% | +2.22% | +18.04% | +3.44% | 80.42B | |
| -0.15% | +4.31% | +46.03% | +248.86% | 61.71B | |
| -1.43% | -16.89% | -40.94% | -50.82% | 52.04B | |
| +0.41% | +71.90% | +71.90% | +71.90% | 55.29B | |
| -0.51% | +11.45% | +147.14% | +105.09% | 19.77B | |
| +1.93% | -1.96% | +45.91% | +27.11% | 20.05B | |
| -1.27% | +2.17% | +24.97% | +65.40% | 15.89B | |
| -0.99% | -1.86% | +31.36% | -76.31% | 15.67B | |
| +1.30% | +3.59% | +3.31% | +862.96% | 14.49B | |
| Average | +0.21% | +1.85% | +39.42% | +122.59% | 36.4B | |
| Weighted average by Cap. | +0.17% | +0.46% | +33.61% | +85.23% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 9.42B 7.94B 7.25B 6.92B 12.84B 854B 13.28B 84.17B 33.47B 411B 35.34B 34.61B 1,436B | 9.36B 7.88B 7.2B 6.87B 12.75B 848B 13.19B 83.58B 33.24B 408B 35.09B 34.37B 1,426B |
| Net income | 1.86B 1.57B 1.43B 1.37B 2.54B 169B 2.63B 16.65B 6.62B 81.35B 6.99B 6.85B 284B | 2B 1.68B 1.54B 1.47B 2.72B 181B 2.82B 17.85B 7.1B 87.21B 7.49B 7.34B 305B |
| Net Debt | -46.71M -39.36M -35.92M -34.29M -63.67M -4.23B -65.85M -417M -166M -2.04B -175M -172M -7.12B | -3.26B -2.74B -2.5B -2.39B -4.44B -295B -4.59B -29.09B -11.57B -142B -12.21B -11.96B -496B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/02/26 | 195.50 $ | +2.25% | 1,657,480 |
| 11/02/26 | 191.20 $ | +1.17% | 996,929 |
| 10/02/26 | 188.99 $ | -2.49% | 1,836,221 |
| 09/02/26 | 193.81 $ | -3.66% | 2,096,252 |
| 06/02/26 | 201.18 $ | +8.53% | 3,404,876 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- BIIB Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition